Advertisement
Canada markets open in 6 hours 40 minutes

  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CAD/USD

    0.7316
    -0.0005 (-0.07%)
     

  • CRUDE OIL

    83.66
    +0.30 (+0.36%)
     

  • Bitcoin CAD

    91,275.02
    +337.42 (+0.37%)
     

  • CMC Crypto 200

    1,414.17
    -9.93 (-0.70%)
     

  • GOLD FUTURES

    2,338.20
    -3.90 (-0.17%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ futures

    17,733.50
    +126.75 (+0.72%)
     

  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6836
    0.0000 (0.00%)
     

Company News For Jul 9, 2019

Zacks Equity Research

  • AZZ Inc.’s AZZ shares jumped 6% after the company reported first quarter fiscal 2020 earnings per share of $0.81, surpassing the Zacks Consensus Estimate of $0.71

  • Intra-Cellular Therapies, Inc.’s ITCI shares dropped 13.1% after the company announced mixed results from two Phase 3 clinical trials which evaluated lumateperone used to treat depressive episodes related to bipolar depression

  • Shares of Deutsche Bank DB lost 6.1% after the company announced plans to slash its workforce by 18,000 jobs by 2022 in order to enhance its profitability

  • Shares of CannTrust Holdings Inc. CTST fell 22.5% after Health Canada issued a notice to the company which stated that its greenhouse facility in Ontario was non-complaint with a few regulations


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Deutsche Bank Aktiengesellschaft (DB) : Free Stock Analysis Report
 
AZZ Inc. (AZZ) : Free Stock Analysis Report
 
Intra-Cellular Therapies Inc. (ITCI) : Free Stock Analysis Report
 
CannTrust Holdings Inc. (CTST) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.